Freeline Therapeutics Holdings plc - ADR Forecast, price target & analysts
$6.48
0.00%
Nasdaq,
Fri, Nov 15 2024
Freeline Therapeutics Holdings plc - ADR Target price 2024 - Analyst rating & recommendation
Powered by
Freeline Therapeutics Holdings plc - ADR Classifications & Recommendation:
Hold
100%
Freeline Therapeutics Holdings plc - ADR Price Target
| Target Price | $6.50 |
| Price | $6.48 |
| Potential |
0.31%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Freeline Therapeutics Holdings plc - ADR price target 2025.
The average Freeline Therapeutics Holdings plc - ADR target price is $6.50.
This is
0.31%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Freeline Therapeutics Holdings plc - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Freeline Therapeutics Holdings plc - ADR stock has an average upside potential 2025 of
0.31%
register free of charge
|
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
